Europe Vascular Stent Market Research Report – Segmented By Product, Type, Mode of Delivery, Material, End-user, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis From 2026 to 2034

ID: 2633
Pages: 145

Market Size, 2025

$6.23 Bn

Market Estimate, 2026

$7.20 Bn

Market Forecast, 2034

$22.88 Bn

CAGR, 2026–2034

15.5%

Executive Summary: Europe Vascular Stent Market

  • Market Scope: Comprehensive European vascular stent market analysis covering products, material types, delivery modes, end-user settings, regional country frameworks, and cardiovascular treatment adoption metrics.
  • Market Valuation: Valued at USD 6.23 billion (2025), estimated at USD 7.20 billion in 2026, and projected to reach USD 22.88 billion by 2034, registering a dynamic CAGR of 15.5% (2026–2034).
  • Primary Growth Drivers: Rising incidence of cardiovascular diseases (CVDs), expanding elderly populace across Europe, and a growing medical shift toward minimally invasive stent procedures over outdated surgical methods. Key regional boosts include favorable reimbursement policies in countries like the UK and Germany, counterbalanced by strict government regulations and occasional product recalls.

Key Market Segment Metrics (2026–2034)

Category Leading Segment (2025 Position) Fastest-Growing Segment
By Product Coronary stents (held the largest market share backed by high volumes of cardiac interventions) Peripheral stents and EVAR stent grafts
By Type Drug-eluting stents (dominated clinical applications to prevent restenosis) Bioabsorbable stents segment
By Mode of Delivery Self-expanding and balloon-expanding stents (integral formats for varied vessel diameters) Advanced self-expanding peripheral systems
By Material Metal-based mesh configurations (dominated traditional structural applications) Polymer and bioresorbable material variants
By End User Hospitals (accounted for the primary healthcare delivery setting for vascular interventions) Specialized cardiovascular research institutes
By Region / Country Germany (projected to dominate regional growth due to lifestyle changes and high CVD occurrence rates) The UK and France (supported by favorable governmental reimbursement policies)

Major Market Players & Market Structure

Market Structure: Highly competitive European cardiovascular medical device market featuring global med-tech leaders and specialized European developers competing intensely on clinical efficacy, material innovation, and strict regulatory compliance.

Key Companies: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, W. L. Gore & Associates, Inc., C. R. Bard, Inc., Endologix, Inc., Lombard Medical Technologies plc, Translumina GmbH, and JOTEC GmbH.

Europe Vascular Stent Market Size

The Europe vascular stent market size was valued at USD 6.23 billion in 2025 and is anticipated to reach USD 7.20 billion in 2026 from USD 22.88 billion by 2034, growing at a CAGR of 15.5% during the forecast period from 2026 to 2034.

The primary function of a vascular stent is to help in keeping the clogged artery open which results in better and free blood flow to the heart. The unclogged arteries and increased blood flow substantially reduce the chances of a heart attack. A stent is an expandable and tiny mesh made of metals or polymers. An implanted stent stays in the artery permanently, although an angiography procedure can remove a blocked stent.

The growth of the Europe Vascular Stent Market is mainly driven by the increasing use of vascular stents for cardiovascular diseases. It is further supplemented by the growing preference for stents over other outdated methods which were relatively more invasive. The rising elderly populace in Europe with the consequent incidence of CVDs is also a significant promoter of market growth.

The restraints faced by the market include the stringent regulation policies by governmental bodies and incidences of product failure and recalls.

REGIONAL ANALYSIS

Regionally, Europe was the second leading region in the global vascular stent market in 2025. Growing usage of vascular stents for heart-related problems is the primary factor driving the European market. Further, the increasing importance of stents over the outdated methods which were relatively more invasive accelerating the vascular stent market growth.

Germany is likely to dominate the European vascular stent market growth over the forecast period due to the unhealthy lifestyle changes, increasing the occurrence rate of cardiovascular situations is driving the market.

Following Germany, UK, France and other European countries are performing well. Favourable reimbursement policies by the government of the European region, particularly in the UK and Germany has increased the acquisition of the stents importantly. However, due to strict regulations by the governmental policies, and growing occurrence rate of product failures and recalls, and approvals for the product launches is one crucial factor restraining the vascular stent market growth over the analysis period.

KEY MARKET PLAYERS

Companies playing a leading role in the European Vascular Stent Market include

  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • BIOTRONIK SE & Co. KG
  • B. Braun Melsungen AG
  • Terumo Corporation
  • STENTYS SA
  • MicroPort Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts
  • W. L. Gore & Associates, Inc.
  • C. R. Bard, Inc.
  • Endologix, Inc.
  • Lombard Medical Technologies plc
  • Translumina GmbH
  • JOTEC GmbH

MARKET SEGMENTATION

This research report on the Europe Vascular Stent Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2032.

By Product

  • Peripheral Stents
  • Coronary Stents
  • EVAR Stent Grafts.

By Type

  • Bare-Metal Stents
  • Drug-Eluting Stents
  • Bioabsorbable Stents.

By Mode of Delivery

  • Self-Expanding Stents
  • Balloon Expanding Stents.

By Material

  • Metal
  • Polymer.

By End User

  • Hospitals
  • Research Institutes.

By Country

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe.

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Related Reports

Click for Request Sample